Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900

Today's dementia research investments are tomorrow's breakthroughs.

That's why we invested $100 million in research in 2023 — the most the Alzheimer’s Association has devoted to dementia research in a single year. Help us speed scientific progress toward a world without Alzheimer's and all other dementia while providing care and support to those facing Alzheimer's today.

Donate Today

Research Momentum
Share or Print this page
Share or Print this page

In 2023, the Alzheimer's Association invested a record-breaking $100 million in research initiatives.

This unparalleled commitment to dementia science is our biggest single-year investment since the Alzheimer's Association was founded in 1980. And we have the momentum to keep going.

As the world's largest nonprofit funder of Alzheimer's research, the Alzheimer's Association has played a vital role in nearly every significant development in dementia research. Our strategic investments go toward advancing understanding of the disease, identifying new treatment strategies, improving care for people with dementia and furthering our knowledge of brain health.

Join the worldwide movement to fight Alzheimer’s and all other dementia when you support the Alzheimer’s Association.

Donate Today

Alzheimer's Association research funding in action


"This opens a new door for Alzheimer’s research. And through that door are new opportunities for treatments."

– Yakeel T. Quiroz, Ph.D., whose work is partially funded by an Alzheimer's Association grant. Quiroz studies how a rare gene variant — the Christchurch variant — may be a key to slowing the progression of Alzheimer's. Learn more about Quiroz's research.


"My focus on the Black community in this grant is due to the underrepresentation of Black people in research, but overrepresentation in poor health outcomes."

– Antoine Trammell, M.D., MPH, Alzheimer's Association Research Grant recipient. Trammell examines whether a blood pressure medication could decrease the incidence of cognitive impairment and dementia in Black people. Learn more about Trammell's research.


"As we continue to move research forward and give patients access to novel therapies, I look forward to the opportunities to slow disease progression in the future."

– Ross Paterson, Ph.D., Part the Cloud grant recipient. Paterson's study aims to identify a novel drug therapy to reduce dementia-related tau production in people with Alzheimer’s. Learn more about Paterson's research.

The Alzheimer's Association is the only voluntary health organization tackling Alzheimer's and dementia from all angles and in all communities. $100 million is just the beginning.

From funding high-impact, best-in-class research projects…

The International Research Grant Program supports investigators at every professional stage and includes categories designed to address gaps in research efforts.

Part the Cloud funds novel research ideas to accelerate them from the laboratory, through clinical trials and into practice.

…to connecting people with trials and treatments…

TrialMatch® is a free service that connects individuals living with Alzheimer's, caregivers and healthy volunteers to clinical trials that may advance Alzheimer's research.

Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) connects clinical data from Alzheimer’s patients to medical professionals and researchers, promoting information sharing and education.

A study for people from diverse backgrounds, New IDEAS uses medical brain imaging to inform more accurate diagnoses and care for people with memory concerns.

The clinical trial U.S. POINTER evaluated the impact of lifestyle interventions on cognitive function — the first such study to be conducted in a large group of Americans across the U.S.

…to bringing the research community together…

Alzheimer's Association International Conference® is the largest international meeting dedicated to advancing dementia science. AAIC convenes researchers, clinicians and dementia professionals from all career stages.

Alzheimer's & Dementia is the top-ranking peer-reviewed journal of dementia science and the parent of two companion journals.

An inclusive global network of scientists, clinicians and dementia professionals, ISTAART has more than 10,000 members in over 120 countries.


…the Alzheimer's Association is the organization that keeps the momentum going.

We are dedicated to accelerating the global effort to eliminate Alzheimer's and all other dementia. Learn more about projects the Association funds, conferences we convene, our advocacy efforts and other initiatives that show our commitment to research.

A world without Alzheimer's and all other dementia is within reach. But we can't lose momentum now.

Donate Today

Not only is the Alzheimer's Association the largest nonprofit funder of Alzheimer's research, but we are also one of the most trustworthy nonprofits. We've earned four stars from Charity Navigator and Platinum from Candid — the highest possible ratings. When you support the Alzheimer's Association, you can be confident you're helping to further the fight against Alzheimer's and all other dementia.